NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Nutex Health Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$191.25+5.15 (+2.77%)
Close on Oct 19, 2026
- Market cap
- $1.34B
- P/E (TTM)
- 7.5
- Dividend yield
- –
Nutex Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Business Services, NEC companies for comparison
Valuation
| Measure | Nutex Health | Industry median |
|---|---|---|
| Market Cap | $1.31B | $288.87M |
| Enterprise Value | $1.26B | $296.43M |
| PE Ratio | 7.53 | 25.42 |
| PS Ratio | 1.55 | 2.45 |
| PB Ratio | 3.32 | 2.73 |
| P/TBV Ratio | 3.64 | 4.95 |
| P/FCF Ratio | 4.78 | 15.04 |
| P/OCF Ratio | 4.68 | 13.19 |
Enterprise value
| Measure | Nutex Health | Industry median |
|---|---|---|
| EV / Sales | 1.48 | 2.21 |
| EV / EBITDA | 3.26 | 16.37 |
| EV / EBIT | 3.45 | 21.97 |
| EV / FCF | 4.58 | 15.16 |
Income (trailing twelve months)
| Measure | Nutex Health | Industry median |
|---|---|---|
| Revenue | $846.72M | $289.17M |
| Gross Profit | $434.03M | $161.98M |
| Operating Income | $364.27M | -$613.24K |
| Pretax Income | $343.48M | -$294.07K |
| Net Income | $179.92M | -$301.07K |
| EBITDA | $385.27M | -$156.35K |
| EPS (Diluted) | $25.40 | $0.00 |
Margins
| Measure | Nutex Health | Industry median |
|---|---|---|
| Gross Margin | 51.3% | 55.8% |
| Operating Margin | 43.0% | -1.81% |
| Pretax Margin | 40.6% | -0.50% |
| Profit Margin | 21.2% | -1.80% |
| EBITDA Margin | 45.5% | 0.60% |
| FCF Margin | 32.4% | 10.0% |
Returns
| Measure | Nutex Health | Industry median |
|---|---|---|
| Return on Equity (ROE) | 57.2% | 0.83% |
| Return on Assets (ROA) | 19.9% | -2.82% |
| Return on Invested Capital (ROIC) | 142.1% | -0.05% |
| Return on Capital Employed (ROCE) | 43.0% | -0.44% |
Growth
| Measure | Nutex Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 6.88% | 9.72% |
| Net Income Growth (YoY) | 218.8% | 7.14% |
| EPS Growth (YoY) | 159.7% | 8.91% |
| FCF Growth (YoY) | 229.4% | 17.2% |
| Revenue Growth (3Y CAGR) | 58.6% | 7.66% |
| Revenue Growth (5Y CAGR) | 26.1% | 12.4% |
| EPS Growth (5Y CAGR) | -17.2% | 12.4% |
Balance sheet
| Measure | Nutex Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $205.21M | $43.42M |
| Total Debt | $39.60M | $204.00M |
| Net Cash (Debt) | $165.61M | $2.04M |
| Net Cash Per Share | $24.18 | $0.13 |
| Equity (Book Value) | $394.32M | $52.29M |
| Book Value Per Share | $57.58 | $1.90 |
| Tangible Book Value | $359.82M | $3.06M |
| Working Capital | $468.43M | $15.22M |
Financial position
| Measure | Nutex Health | Industry median |
|---|---|---|
| Current Ratio | 5.00 | 1.40 |
| Quick Ratio | 1.75 | 0.94 |
| Debt / Equity | 0.10 | 0.53 |
| Debt / EBITDA | 0.10 | 2.78 |
| Debt / FCF | 0.14 | 2.83 |
| Net Debt / EBITDA | -0.43 | 1.50 |
| Interest Coverage | 18.41 | -0.66 |
Cash flow (trailing twelve months)
| Measure | Nutex Health | Industry median |
|---|---|---|
| Operating Cash Flow | $279.62M | $8.52M |
| Capital Expenditures | -$5.45M | -$5.56M |
| Free Cash Flow | $274.17M | $43.71M |
| FCF Per Share | $40.04 | $0.69 |
Efficiency
| Measure | Nutex Health | Industry median |
|---|---|---|
| Asset Turnover | 0.94 | 0.64 |
| Inventory Turnover | 127.33 | 13.06 |
| Revenue Per Employee | $896.95K | $392.99K |
| Profits Per Employee | $190.59K | -$4.94K |
| Employee Count | 944 | 544 |
Dividends and yields
| Measure | Nutex Health | Industry median |
|---|---|---|
| Earnings Yield | 13.7% | -0.85% |
| FCF Yield | 20.9% | 3.98% |
Shares
| Measure | Nutex Health | Industry median |
|---|---|---|
| Shares Outstanding | 6,847,970 | 60,427,600 |
| Shares Change (YoY) | 14.7% | 2.21% |
| Shares Change (QoQ) | -1.55% | 0.06% |
| Shares Held by Institutions | 42.9% | 66.9% |
Taxes
| Measure | Nutex Health | Industry median |
|---|---|---|
| Income Tax | $70.99M | $1.69M |
| Effective Tax Rate | 20.7% | 22.0% |
Scores
| Measure | Nutex Health | Industry median |
|---|---|---|
| Graham Number | $181.41 | $15.96 |
| Graham Upside | -5.15% | -56.1% |
| Altman Z-Score | 4.17 | 1.51 |
| Piotroski F-Score | 7 | 5 |
Calculated by StockData from Nutex Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.